Changes in T4/T8 Ratio over a Ten Years Period Related to the Factor VIII Concentrates Used in a Group of HIV Negative Haemophiliacs

• References

• 1 Berntorp E. Impact of replacement therapy on the evolution of HIV infection in haemophiliacs. Thromb Haemost 1994; 71: 678-683
• 2 Cuthbert RJ, Ludlam CA, Tucker J, Steel CM, Beatson D, Rebus S, Peutherer JF. Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. BMJ 1990; 301: 956-961
• 3 Fukutake K, Fujimaki M, Hanbusa S, Nagaki MI, Mimaya J, Shirahata A. Multicenter study on the influence of long-term continuous use of ultrapuri- fied factor VIII preparation on the immunological status of HIV infected and non-infected haemophilia A patients. XHIth International Congress of the International Society on Thrombosis and Haemostasis. Amsterdam: The Netherlands: 1991. Abstr 1075
• 4 Mannucci PM, Brettler DB, Aledort LM, Lusher JM, Abildgaard CF, Schwartz RS, Hurst D. Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. Blood 1994; 83: 1958-1962
• 5 Gomperts ED, de Biasi R, De Vrekers R. The impact of clotting factor concentrates on the immune system in individuals with hemophilia. Transfusion Med Rev 1992; 1: 44-54